Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Theophylline by Cyrano Therapeutics for Dysgeusia (Taste Disorders): Likelihood of Approval
Theophylline is under clinical development by Cyrano Therapeutics and currently in Phase II for Dysgeusia (Taste Disorders). According to GlobalData,...
Data Insights
Theophylline by Cyrano Therapeutics for Hyposmia: Likelihood of Approval
Theophylline is under clinical development by Cyrano Therapeutics and currently in Phase II for Hyposmia. According to GlobalData, Phase II...